Category: New products
-
Measles-Rubella Patch Vaccine Shown Effective as Injection
A clinical trial shows a peel-and-stick patch device is as effective as a standard syringe injection in delivering a vaccine that protects against measles and rubella.
-
Rare Disease Search Adds Large Language Model A.I.
A company offering a search engine to help diagnose rare diseases is integrating generative models from Open AI into its artificial intelligence algorithms.
-
Infographic – Climate Start-Ups Still Gaining Venture Funds
Despite a sharp downturn in venture dollars from 2021, new climate and weather forecasting companies continue to attract investments at historically high rates.
-
Quantum Technology Start-Up Accelerator Unveiled
A business incubator is underway to help start-up enterprises in Denmark working in quantum technologies, particularly with defense-related applications.
-
$15M Alternative Chicken, Fish Challenge Finalists Named
An international challenge competition seeking sustainable but realistic alternatives to natural chicken and fish protein named its six finalist teams.
-
Crispr Therapy Shown to Remove E. Coli in Gut
New research with lab animals shows gene-edited viruses can target and remove harmful E. coli bacteria from the gut, including strains usually resistant to antibiotics.
-
Trial Underway Testing Psychedelic Drug for Depression
The first participant in a clinical trial received a dose of a psychedelic therapy, assessing the experimental compound in people with treatment resistant depression.
-
DNA Test Detects Early Bladder Cancer in Urine
A genomic analysis of urine samples is shown to predict the most common form of bladder cancer years before symptoms appear.
-
Biotech to Design Disease-Blocking Drugs, Gains $75M
A new company that says it can stop disease-causing proteins from forming in cells began public operations today, and is raising $75 million in its first venture round.
-
Light-Activated Therapy Improves Vision in Inherited Disease Trial
A clinical trial shows a light-activated protein from an injected gene improves visual abilities in people with advanced retinitis pigmentosa, an inherited eye disorder.